CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
$0.00-0.63%
OTC PK
| 12/31/2024 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 69.50K | 241.50K | 212.80K | 621.00K | 43.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.50K | 241.50K | 212.80K | 621.00K | 43.20K |
| Operating Income | -69.50K | -241.50K | -212.80K | -621.00K | -43.20K |
| Income Before Tax | -46.90K | -362.70K | -337.10K | -628.50K | -43.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.90K | -362.70K | -337.10K | -628.50K | -43.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.90K | -362.70K | -337.10K | -628.50K | -43.20K |
| EBIT | -69.50K | -241.50K | -212.80K | -621.00K | -43.20K |
| EBITDA | -67.90K | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.02 | -0.02 | -0.03 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.02 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | -0.02 | -0.03 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.02 | 0.00 |
| Average Basic Shares Outstanding | 52.78M | 21.32M | 19.51M | 19.75M | 15.77M |
| Average Diluted Shares Outstanding | 52.78M | 21.32M | 19.51M | 19.75M | 15.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |